Macquarie Maintains Outperform on Imax, Raises Price Target to $55

Benzinga Newsdesk www.benzinga.com Positive 89.3%

Neg 0% Neu 0% Pos 89.3%

Macquarie analyst Chad Beynon maintains Imax (NYSE:IMAX) with a Outperform and raises the price target from $50 to $55.

Comments

No comments yet. Be the first!